Literature DB >> 23804810

LDL particle core enrichment in cholesteryl oleate increases proteoglycan binding and promotes atherosclerosis.

John T Melchior1, Janet K Sawyer, Kathryn L Kelley, Ramesh Shah, Martha D Wilson, Roy R Hantgan, Lawrence L Rudel.   

Abstract

Several studies in humans and animals suggest that LDL particle core enrichment in cholesteryl oleate (CO) is associated with increased atherosclerosis. Diet enrichment with MUFAs enhances LDL CO content. Steroyl O-acyltransferase 2 (SOAT2) is the enzyme that catalyzes the synthesis of much of the CO found in LDL, and gene deletion of SOAT2 minimizes CO in LDL and protects against atherosclerosis. The purpose of this study was to test the hypothesis that the increased atherosclerosis associated with LDL core enrichment in CO results from an increased affinity of the LDL particle for arterial proteoglycans. ApoB-100-only Ldlr(-/-) mice with and without Soat2 gene deletions were fed diets enriched in either cis-MUFA or n-3 PUFA, and LDL particles were isolated. LDL:proteogylcan binding was measured using surface plasmon resonance. Particles with higher CO content consistently bound with higher affinity to human biglycan and the amount of binding was shown to be proportional to the extent of atherosclerosis of the LDL donor mice. The data strongly support the thesis that atherosclerosis was induced through enhanced proteoglycan binding of LDL resulting from LDL core CO enrichment.

Entities:  

Keywords:  cholesterol; fatty acid; glycosaminoglycan; lipoprotein

Mesh:

Substances:

Year:  2013        PMID: 23804810      PMCID: PMC3735946          DOI: 10.1194/jlr.M039644

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  43 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  ACAT2 contributes cholesteryl esters to newly secreted VLDL, whereas LCAT adds cholesteryl ester to LDL in mice.

Authors:  Richard G Lee; Ramesh Shah; Janet K Sawyer; Robert L Hamilton; John S Parks; Lawrence L Rudel
Journal:  J Lipid Res       Date:  2005-04-01       Impact factor: 5.922

3.  Eukaryotic expression of recombinant biglycan. Post-translational processing and the importance of secondary structure for biological activity.

Authors:  A M Hocking; R A Strugnell; P Ramamurthy; D J McQuillan
Journal:  J Biol Chem       Date:  1996-08-09       Impact factor: 5.157

4.  Relation of plasma phospholipid and cholesterol ester fatty acid composition to carotid artery intima-media thickness: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  J Ma; A R Folsom; L Lewis; J H Eckfeldt
Journal:  Am J Clin Nutr       Date:  1997-02       Impact factor: 7.045

5.  Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential.

Authors:  Richard G Lee; Kathryn L Kelley; Janet K Sawyer; Robert V Farese; John S Parks; Lawrence L Rudel
Journal:  Circ Res       Date:  2004-10-14       Impact factor: 17.367

6.  Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins.

Authors:  K D O'Brien; K L Olin; C E Alpers; W Chiu; M Ferguson; K Hudkins; T N Wight; A Chait
Journal:  Circulation       Date:  1998-08-11       Impact factor: 29.690

7.  Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice.

Authors:  M M Véniant; C H Zlot; R L Walzem; V Pierotti; R Driscoll; D Dichek; J Herz; S G Young
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

8.  Effects of fish oil on oxidation resistance of VLDL in hypertriglyceridemic patients.

Authors:  M F Hau; A H Smelt; A J Bindels; E J Sijbrands; A Van der Laarse; W Onkenhout; W van Duyvenvoorde; H M Princen
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-09       Impact factor: 8.311

9.  Dietary polyunsaturated fat modifies low-density lipoproteins and reduces atherosclerosis of nonhuman primates with high and low diet responsiveness.

Authors:  L L Rudel; F L Johnson; J K Sawyer; M S Wilson; J S Parks
Journal:  Am J Clin Nutr       Date:  1995-08       Impact factor: 7.045

10.  Compared with dietary monounsaturated and saturated fat, polyunsaturated fat protects African green monkeys from coronary artery atherosclerosis.

Authors:  L L Rudel; J S Parks; J K Sawyer
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-12       Impact factor: 8.311

View more
  12 in total

1.  Botanical oils enriched in n-6 and n-3 FADS2 products are equally effective in preventing atherosclerosis and fatty liver.

Authors:  Swapnil V Shewale; Elena Boudyguina; Xuewei Zhu; Lulu Shen; Patrick M Hutchins; Robert M Barkley; Robert C Murphy; John S Parks
Journal:  J Lipid Res       Date:  2015-04-28       Impact factor: 5.922

2.  Sterol O-Acyltransferase 2-Driven Cholesterol Esterification Opposes Liver X Receptor-Stimulated Fecal Neutral Sterol Loss.

Authors:  Manya Warrier; Jun Zhang; Kanwardeep Bura; Kathryn Kelley; Martha D Wilson; Lawrence L Rudel; J Mark Brown
Journal:  Lipids       Date:  2016-01-04       Impact factor: 1.880

3.  Cholesterol esters (CE) derived from hepatic sterol O-acyltransferase 2 (SOAT2) are associated with more atherosclerosis than CE from intestinal SOAT2.

Authors:  Jun Zhang; Janet K Sawyer; Stephanie M Marshall; Kathryn L Kelley; Matthew A Davis; Martha D Wilson; J Mark Brown; Lawrence L Rudel
Journal:  Circ Res       Date:  2014-09-19       Impact factor: 17.367

Review 4.  A role for proteoglycans in vascular disease.

Authors:  Thomas N Wight
Journal:  Matrix Biol       Date:  2018-02-27       Impact factor: 11.583

5.  High-oleic canola oil consumption enriches LDL particle cholesteryl oleate content and reduces LDL proteoglycan binding in humans.

Authors:  Peter J H Jones; Dylan S MacKay; Vijitha K Senanayake; Shuaihua Pu; David J A Jenkins; Philip W Connelly; Benoît Lamarche; Patrick Couture; Penny M Kris-Etherton; Sheila G West; Xiaoran Liu; Jennifer A Fleming; Roy R Hantgan; Lawrence L Rudel
Journal:  Atherosclerosis       Date:  2014-12-09       Impact factor: 5.162

6.  Targeted Knockdown of Hepatic SOAT2 With Antisense Oligonucleotides Stabilizes Atherosclerotic Plaque in ApoB100-only LDLr-/- Mice.

Authors:  John T Melchior; John D Olson; Kathryn L Kelley; Martha D Wilson; Janet K Sawyer; Kerry M Link; Lawrence L Rudel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-07-30       Impact factor: 8.311

7.  Seeking a unique lipid signature predicting cardiovascular disease risk.

Authors:  J Mark Brown; Stanley L Hazen
Journal:  Circulation       Date:  2014-03-12       Impact factor: 29.690

8.  Acute sterol o-acyltransferase 2 (SOAT2) knockdown rapidly mobilizes hepatic cholesterol for fecal excretion.

Authors:  Stephanie M Marshall; Anthony D Gromovsky; Kathryn L Kelley; Matthew A Davis; Martha D Wilson; Richard G Lee; Rosanne M Crooke; Mark J Graham; Lawrence L Rudel; J Mark Brown; Ryan E Temel
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

9.  Sex-Specific Associations between Particulate Matter Exposure and Gene Expression in Independent Discovery and Validation Cohorts of Middle-Aged Men and Women.

Authors:  Karen Vrijens; Ellen Winckelmans; Maria Tsamou; Willy Baeyens; Patrick De Boever; Danyel Jennen; Theo M de Kok; Elly Den Hond; Wouter Lefebvre; Michelle Plusquin; Hans Reynders; Greet Schoeters; Nicolas Van Larebeke; Charlotte Vanpoucke; Jos Kleinjans; Tim S Nawrot
Journal:  Environ Health Perspect       Date:  2016-10-14       Impact factor: 9.031

Review 10.  Role of cis-Monounsaturated Fatty Acids in the Prevention of Coronary Heart Disease.

Authors:  Peter J Joris; Ronald P Mensink
Journal:  Curr Atheroscler Rep       Date:  2016-07       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.